Crossmark

Superdiluted atropine at 0.01% reduces myopia progression in children and adolescents. A 5-year study of safety and effectiveness

Crossref DOI link: https://doi.org/10.1016/j.oftale.2018.08.011

Published Print: 2019-03

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Asensio-Sánchez, V.M.
License Information

Text and Data Mining valid from 2019-03-01
More Information

This article is maintained by: Elsevier

Article Title: Superdiluted atropine at 0.01% reduces myopia progression in children and adolescents. A 5-year study of safety and effectiveness

Journal Title: Archivos de la Sociedad Española de Oftalmología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.oftale.2018.08.011

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.oftal.2018.08.007

Content Type: simple-article

Copyright: © 2018 Sociedad Española de Oftalmología. Published by Elsevier España, S.L.U. All rights reserved.